Nuwellis, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
NUWE$5.24+6.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| 2025 | 2024 | |
|---|---|---|
| Operating Activities: | ||
| Net loss | $(15,099) | $(9,697) |
| Adjustments to reconcile net loss to cash flows used in operating activities: | ||
| Depreciation and amortization | 166 | 227 |
| Stock-based compensation expense | 103 | 374 |
| Change in fair value of warrant liabilities | (4,101) | (4,602) |
| Financing expense | 10,553 | 5,607 |
| Amortization of operating lease right-of-use asset | 161 | 150 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 586 | 658 |
| Inventory, net | (471) | 120 |
| Other current assets | (461) | (275) |
| Other assets and liabilities | 35 | (3) |
| Lease liability | (162) | (160) |
| Accounts payable and accrued expenses | 910 | (486) |
| Net cash used in operating activities | (7,780) | (8,087) |
| Investing Activities: | ||
| Purchases of property and equipment | (102) | (37) |
| Net cash used in investing activities | (102) | (37) |
| Financing Activities: | ||
| Issuance of Common Stock and warrants from offering, net | 3,999 | 2,403 |
| Issuance of Common Stock from ATM, net | 1,889 | — |
| Proceeds from the exercise of Series J Convertible Preferred Warrants | — | 501 |
| Proceeds from the exercise of April 2024 Warrants | — | 1,182 |
| Issuance of July and August 2024 Common Stock and Warrants | — | 2,160 |
| Net cash provided by financing activities | 5,888 | 6,246 |
| Effect of exchange rate changes on cash | (7) | (15) |
| Net decrease in cash and cash equivalents | (2,001) | (1,893) |
| Cash and cash equivalents - beginning of period | 5,095 | 3,800 |
| Cash and cash equivalents - end of period | $3,094 | $1,907 |
| Supplemental cash flow information | ||
| Reclassification of April 2024 warrants to equity | $— | $4,217 |
| Issuance of Series J Preferred Stock for exercise of Warrants | $— | $1,857 |
| Series A warrants conversion to equity | $8,439 | $— |
| Series B warrant exercises | $2,055 | $— |
| Issuance of Common Stock for conversion of Series J Preferred Stock | $— | $1,535 |
| Issuance of Common Stock for conversion of Series F-1 Preferred Stock | $1,100 | $— |
| Deemed dividend on Series J Preferred Stock | $3 | $(541) |
| Common stock offering costs included in prepaids | $— | $306 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.